Niki BioSolutions, Inc. NIKI
1.57 USD +0.07 (+4.67%)
Nov 6, 2026, 11:55 AM EST
1.50 Day range 1.58
1.42 52-week range 17.20
- YTD
- -85.19%
- 1 year
- -88.50%
- Market cap
- 4.93M
- EPS (ttm)
- -2.90
- YTD return
- -85.19%
- 1-year return
- -88.50%
- Volume
- 3.92K
- Avg volume
- 98.59K
- Open
- 1.50
- Previous close
- 1.50
- Day's range
- 1.50 – 1.58
- 52-week range
- 1.42 – 17.20
30m -0.20 (-11.24%)
Financials — quick view
NIKI Revenue — annual 0
NIKI Net income — annual -1.36M
NIKI EPS — annual -1.90
News
New York State Department Of Health Provides Clinical Laboratory Evaluation Program Test Approval To Niki BioSolutions' DiamiR Biosciences Subsidiary For Its APOE Genotyping Test 
12 Health Care Stocks Moving In Tuesday's After-Market Session 
Niki BioSolutions' DiamiR Biosciences Subsidiary To Perform Apolipoprotein E Genotyping On Plasma Samples From Global Alzheimer’s Platform Foundation Bio-Hermes-002 Trial Group 
12 Health Care Stocks Moving In Tuesday's After-Market Session - 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Niki BioSolutions Enters At The Market Offering Agreement On October 9, 2026; May Sell Common Stock Up To $1.40M Aggregate Maximum Offering Price
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session - 12 Health Care Stocks Moving In Thursday's Pre-Market Session
Niki BioSolutions’ DiamiR Biosciences Agrees To Provide Progressive Medical Research With Apolipoprotein E Genotyping Services In Support Of Ongoing Clinical And Translational Research Programs
Your note
Sign in to keep a note on NIKI — it syncs with the Stock Master app.